Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
This study has been completed.
Study NCT00527917   Information provided by Watson Pharmaceuticals
First Received: September 7, 2007   Last Updated: November 6, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interstitial Cystitis
Additional conditions recognized in this trial
Cystitis
Cystitis, Interstitial
Syndrome
More general conditions related to this trial
Disease
Pathologic Processes
Urinary Bladder Diseases
Urologic Diseases
Interventions listed in this trial
Uracyst
placebo
Sponsors listed in this trial
Watson Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services